Neurocrine Bioscience buy JPMorgan Chase & Co.
Start price
20.03.24
/
50%
€128.85
Target price
20.03.25
€145.64
Performance (%)
4.42%
Price
24.07.24
€134.55
Summary
This prediction is currently active. The BUY prediction by JPMorgan_Chase___Co_ shows slight gains of 4.42%. This prediction currently runs until 20.03.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | 1.701% | 1.701% |
iShares Core DAX® | -0.612% | 0.567% |
iShares Nasdaq 100 | -3.018% | -3.205% |
iShares Nikkei 225® | -2.647% | 0.330% |
iShares S&P 500 | -1.932% | -1.126% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at JPMorgan Chase & Co. from $148.00 to $158.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€135.00
10.07.24
10.07.24
€159.75
10.07.25
10.07.25
-0.33%
24.07.24
24.07.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€124.00
23.02.24
23.02.24
€136.69
23.02.25
23.02.25
8.51%
24.07.24
24.07.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.25
13.09.23
13.09.23
€124.83
13.09.24
13.09.24
25.45%
24.07.24
24.07.24